Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors
2011 ◽
Vol 69
(4)
◽
pp. 1099-1105
◽
Yoshitaka Seki
◽
Noboru Yamamoto
◽
Yosuke Tamura
◽
Yasushi Goto
◽
Takashi Shibata
◽
...
2015 ◽
Vol 75
(6)
◽
pp. 1155-1161
◽
Satoru Kitazono
◽
Yutaka Fujiwara
◽
Shinji Nakamichi
◽
Hidenori Mizugaki
◽
Hiroshi Nokihara
◽
...
2012 ◽
Vol 23
◽
pp. xi110
S. Takahashi
◽
T. Ura
◽
K. Nakano
◽
K. Chin
◽
M. Yokoyama
◽
...
Koichiro Watanabe
◽
Hironobu Minami
◽
Satoshi Otsu
◽
Yoshinori Hirashima
◽
Ryotaro Morinaga
◽
...
Tina Cascone
◽
Kenneth R. Hess
◽
Sarina Piha-Paul
◽
David S. Hong
◽
Michael Roxas
◽
...
2017 ◽
Vol 109
(1)
◽
pp. 193-198
◽
Toshihiko Doi
◽
Becker Hewes
◽
Tomoyuki Kakizume
◽
Takeshi Tajima
◽
Norifumi Ishikawa
◽
...
2016 ◽
Vol 27
◽
pp. vii87-vii88
Takashi Seto
◽
Kaname Nosaki
◽
Gen Shinoda
◽
Kensei Hashizume
◽
Iku Yamaguchi
◽
...
2014 ◽
Vol 25
◽
pp. iv383
N. Yamazaki
◽
Y. Kiyohara
◽
S. Yoshikawa
◽
N. Yamamoto
◽
A. Tsutsumida
◽
...
2019 ◽
Vol 84
(2)
◽
pp. 393-404
◽
Toshihiko Doi
◽
Yutaka Fujiwara
◽
Nobuaki Matsubara
◽
Junichi Tomomatsu
◽
Satoru Iwasa
◽
...
2020 ◽
Vol 38
(6)
◽
pp. 1755-1762
◽
Mojun Zhu
◽
Julian R. Molina
◽
Grace K. Dy
◽
Gary A. Croghan
◽
Yingwei Qi
◽
...
2008 ◽
Vol 6
(12)
◽
pp. 124
H. Murakami
◽
N. Yamamoto
◽
N. Boku
◽
K. Yamazaki
◽
N. Yamamoto
◽
...